Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update
1Q FY 2022 revenues of $26.5 million vs. $24.8 million in 4Q FY 2021, representing…
Month: December 2021
Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum Contagiosum
WEST CHESTER, Pa., Dec. 15, 2021 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA),…
Ensysce Biosciences Announces First Patients Enrolled in Phase 1 Study of PF614-MPAR™, its unique technology platform to provide opioid overdose protection
SAN DIEGO, Dec. 15, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
Elucida Oncology to Present Preclinical Data on ELU001 at the Antibody Engineering & Therapeutic Conference
MONMOUTH JUNCTION, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company…
Tricida to Present at the 40th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA) today announced…
UPDATE — PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision
Sandusky, OH, Dec. 15, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) today…
Akoya Biosciences Unveils Comprehensive Roadmap of Innovations at Inaugural Spatial Day Event
Imaged on PhenoCycler-Fusion Zoom In A zoomed in section shows germinal centers with a concentration…
Avenue Therapeutics Announces Closing of Public Offering of Common Stock
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (or the “Company”) (NASDAQ:…
Issuance of 2nd tranche of €500,000 of notes convertibles into new shares
Issuance of 2nd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its…
PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision
Sandusky, OH, Dec. 15, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) today…
Polydex Pharmaceuticals Issues Third Quarter Financial Results
Management continues prudent cash management to weather global challenges TORONTO, Dec. 15, 2021 (GLOBE NEWSWIRE)…
New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey
SALT LAKE CITY, Dec. 15, 2021 (GLOBE NEWSWIRE) — Now is the time when people…
Preclinical tasquinimod data presented at ASH 2021 available on Active Biotech’s website
Lund, December 15, 2021 – Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that preclinical data…
UPDATE – Y-mAbs Announces Pipeline Update
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Oyster Point Pharma Announces Addition To Nasdaq Biotechnology Index
PRINCETON, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Sanara MedTech Inc. Announces the Appointment of Roszell Mack III to its Board of Directors
FORT WORTH, TX, Dec. 15, 2021 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara” or the…
Y-mAbs Announces Pipeline Update
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Orpharm LLC for its Lead Asset, QRX003, for Netherton Syndrome
Orpharm Gains Exclusive Rights to Commercialize QRX003 in Russia and CIS ASHBURN, Va., Dec. 15,…
REPEAT – Tetra Bio-Pharma Announces Pricing of Marketed Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OTTAWA, Dec….
Salarius Pharmaceuticals to Present at the Virtual Life Science Investor Forum
HOUSTON, Dec. 15, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…